PUBLISHER: The Business Research Company | PRODUCT CODE: 1713645
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713645
Rotavirus Vaccine Global Market Report 2025
The rotavirus vaccine is designed to protect against rotavirus infections, which are a common cause of severe diarrhea and gastroenteritis in infants and young children. Administered orally, this vaccine contains live attenuated or inactivated strains of the rotavirus to stimulate an immune response and provide immunity against the virus.
The main types of rotavirus vaccines include rotarix, rotaTeq, rotavac, rotavin-M1, lanzhou lamb, and others. Rotarix is a live attenuated oral vaccine aimed at protecting infants from rotavirus gastroenteritis, which can lead to severe diarrhea and dehydration. The vaccine is used in both pediatric and adult applications, with end users including hospitals, clinics, and academic research institutions.
The rotavirus vaccine market research report is one of a series of new reports from the business research company that provides rotavirus vaccine market statistics, including rotavirus vaccine industry global market size, regional shares, competitors with an rotavirus vaccine market share, detailed rotavirus vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the rotavirus vaccine industry. This rotavirus vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rotavirus vaccine market size has grown rapidly in recent years. It will grow from $9.18 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased awareness of rotavirus, improved healthcare infrastructure, government immunization programs, rising incidence of rotavirus infections, rising birth rates.
The rotavirus vaccine market size is expected to see rapid growth in the next few years. It will grow to $14.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising birth rates, the expansion of vaccination programs, an increased focus on preventive healthcare, economic growth and improved access, and government policies and funding. Major trends in the forecast period include advancements in vaccine technology, advancements in oral-dosing technologies, improved vaccine formulations, combination vaccines, and digital health integration.
The increasing birth rates are expected to drive the growth of the rotavirus vaccine market in the future. Birth rates, which measure the number of live births per 1,000 people in a given population over a specific period, are influenced by factors such as economic stability, growth, and supportive policies such as parental leave, child benefits, and childcare subsidies. Rotavirus vaccines play a crucial role in reducing severe rotavirus gastroenteritis in infants, leading to improved child health outcomes and lower healthcare costs related to rotavirus infections. For example, according to a January 2023 report by the Centers for Disease Control and Prevention (CDC), the United States experienced a 1% increase in registered births, totaling 3,664,292, compared to the previous year. Consequently, the rise in birth rates is expected to boost the demand for rotavirus vaccines.
Key players in the rotavirus vaccine market are focusing on oral-dosing applicators to improve vaccine delivery efficiency and enhance patient compliance. Oral-dosing applicators are devices designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For instance, in November 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, received FDA approval for a new oral-dosing applicator-only formulation of ROTARIX (Rotavirus Vaccine, Live, Oral). This formulation is effective against rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants and simplifies vaccine preparation for healthcare providers by removing the need for dose reconstitution.
In June 2024, Murdoch Children's Research Institute, an Australia-based child health research organization, partnered with Incepta Pharmaceuticals Limited. This collaboration aims to enhance protection for children against rotavirus by developing and distributing effective vaccines. The partnership focuses on expanding access to essential rotavirus vaccines in regions with high infection rates and limited healthcare resources. Incepta Pharmaceuticals Limited, a Bangladesh-based pharmaceutical company, is involved in the development of rotavirus vaccines.
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
North America was the largest region in the rotavirus vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the rotavirus vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rotavirus vaccine market consists of sales of combination vaccines, vaccine delivery systems, vaccine doses, and packs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rotavirus Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rotavirus vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rotavirus vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rotavirus vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Rotarix; RotaTeq; Rotavac; Rotavin-M1; Lanzhou lamb; Other Types
- 2) By Application: Adult; Pediatric
- 3) By End Users: Hospitals; Clinics; Academic Research
- Subsegments:
- 1) By Rotarix: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
- 2) By RotaTeq: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
- 3) By Rotavac: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
- 4) By Rotavin-M1: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
- 5) By Lanzhou Lamb: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
- 6) By Other Types: Emerging Rotavirus Vaccines; Combination Vaccines; Region-Specific Vaccines
- Companies Mentioned: Merck & Co. Inc.; Sanofi S.A.; Abbott Laboratories; GlaxoSmithKline plc; Daiichi Sankyo Company Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Rotavirus Vaccine Market Characteristics
3. Rotavirus Vaccine Market Trends And Strategies
4. Rotavirus Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Rotavirus Vaccine Growth Analysis And Strategic Analysis Framework
- 5.1. Global Rotavirus Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Rotavirus Vaccine Market Growth Rate Analysis
- 5.4. Global Rotavirus Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Rotavirus Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Rotavirus Vaccine Total Addressable Market (TAM)
6. Rotavirus Vaccine Market Segmentation
- 6.1. Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- Other Types
- 6.2. Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adult
- Pediatric
- 6.3. Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Academic Research
- 6.4. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dosing Schedule And Administration
- Efficacy And Safety Profile
- Target Demographics
- 6.5. Global Rotavirus Vaccine Market, Sub-Segmentation Of RotaTeq, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dosing Schedule And Administration
- Efficacy And Safety Profile
- Target Demographics
- 6.6. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotavac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dosing Schedule And Administration
- Efficacy And Safety Profile
- Target Demographics
- 6.7. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotavin-M1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dosing Schedule And Administration
- Efficacy And Safety Profile
- Target Demographics
- 6.8. Global Rotavirus Vaccine Market, Sub-Segmentation Of Lanzhou Lamb, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Dosing Schedule And Administration
- Efficacy And Safety Profile
- Target Demographics
- 6.9. Global Rotavirus Vaccine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Emerging Rotavirus Vaccines
- Combination Vaccines
- Region-Specific Vaccines
7. Rotavirus Vaccine Market Regional And Country Analysis
- 7.1. Global Rotavirus Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Rotavirus Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Rotavirus Vaccine Market
- 8.1. Asia-Pacific Rotavirus Vaccine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Rotavirus Vaccine Market
- 9.1. China Rotavirus Vaccine Market Overview
- 9.2. China Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Rotavirus Vaccine Market
- 10.1. India Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Rotavirus Vaccine Market
- 11.1. Japan Rotavirus Vaccine Market Overview
- 11.2. Japan Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Rotavirus Vaccine Market
- 12.1. Australia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Rotavirus Vaccine Market
- 13.1. Indonesia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Rotavirus Vaccine Market
- 14.1. South Korea Rotavirus Vaccine Market Overview
- 14.2. South Korea Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Rotavirus Vaccine Market
- 15.1. Western Europe Rotavirus Vaccine Market Overview
- 15.2. Western Europe Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Rotavirus Vaccine Market
- 16.1. UK Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Rotavirus Vaccine Market
- 17.1. Germany Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Rotavirus Vaccine Market
- 18.1. France Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Rotavirus Vaccine Market
- 19.1. Italy Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Rotavirus Vaccine Market
- 20.1. Spain Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Rotavirus Vaccine Market
- 21.1. Eastern Europe Rotavirus Vaccine Market Overview
- 21.2. Eastern Europe Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Rotavirus Vaccine Market
- 22.1. Russia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Rotavirus Vaccine Market
- 23.1. North America Rotavirus Vaccine Market Overview
- 23.2. North America Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Rotavirus Vaccine Market
- 24.1. USA Rotavirus Vaccine Market Overview
- 24.2. USA Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Rotavirus Vaccine Market
- 25.1. Canada Rotavirus Vaccine Market Overview
- 25.2. Canada Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Rotavirus Vaccine Market
- 26.1. South America Rotavirus Vaccine Market Overview
- 26.2. South America Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Rotavirus Vaccine Market
- 27.1. Brazil Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Rotavirus Vaccine Market
- 28.1. Middle East Rotavirus Vaccine Market Overview
- 28.2. Middle East Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Rotavirus Vaccine Market
- 29.1. Africa Rotavirus Vaccine Market Overview
- 29.2. Africa Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Rotavirus Vaccine Market Competitive Landscape And Company Profiles
- 30.1. Rotavirus Vaccine Market Competitive Landscape
- 30.2. Rotavirus Vaccine Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis
31. Rotavirus Vaccine Market Other Major And Innovative Companies
- 31.1. Serum Institute of India Private Limited
- 31.2. Sinovac Biotech Ltd.
- 31.3. SK Chemicals Co Ltd
- 31.4. Bharat Biotech International Limited
- 31.5. Walvax Biotechnology Co. Ltd.
- 31.6. Indian Immunologicals Limited
- 31.7. PT Bio Farma
- 31.8. KFF Inc.
- 31.9. Panacea Biotec Limited
- 31.10. Sanyou Biopharmaceuticals Co. Ltd.
- 31.11. Inovio Pharmaceuticals Inc.
- 31.12. Hilleman Laboratories Private Limited
- 31.13. China National Biotec Group Corporation
- 31.14. Vabiotech
- 31.15. Lanzhou Institute of Biological Products Co. Ltd.
32. Global Rotavirus Vaccine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Rotavirus Vaccine Market
34. Recent Developments In The Rotavirus Vaccine Market
35. Rotavirus Vaccine Market High Potential Countries, Segments and Strategies
- 35.1 Rotavirus Vaccine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Rotavirus Vaccine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Rotavirus Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250423_r33547_Rotavirus_Vaccine_GMR_2025
